Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 3 of 3
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Evaluation of Knowledge and Attitudes toward Euthanasia between Physicians and Caregivers
    (Mongolian National University of Medical Sciences, 2023-09-30)
    Sukhbaatar Chuluunsukh
    ;
    ; ; ;
    Tseren Tuvshinjargal
    Objective: This study aimed to estimate the knowledge of the legal regulation of euthanasia and painless death among terminally ill patients, their caregivers, and attending physicians. Methods: The study was conducted using an analytical survey design and evaluated by a questionnaire of the target sample group. Results: According to the patient’s age group, those under 49 were most likely to support euthanasia at 93.1%, and those over 50 were 73.3%. Furthermore, 87.5% of those who said they had financial problems, 91.7% of those who said they had long queues at the hospital, difficulty in getting medical care, 66.7% of those who said they were bedridden or had a lot of pain, and 100% of those who said they would have mental depression or other problems were in favor of euthanasia. In the physicians, 96.6% of the doctors who participated in the study said they knew about euthanasia, 100% of those who believed that euthanasia was ethical and knew the types of euthanasia, and 95% of those who thought that there were ethical differences in the types of euthanasia, supported euthanasia. Conclusion:Our study demonstrated that caregivers generally support the legalization of euthanasia. 70.8% of those who said that euthanasia could be performed by medical indications, 79.2% of those who said that it could be performed at the request of the patient, 54.2% of those who said that it could be performed at the request of the family of a patient without legal capacity, and 35.4% of those who said that it could be performed at the request of a treating physician tended to support euthanasia.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    SARS-CoV-2 seroprevalence in Mongolia: Results from a national population survey
    (Elsevier BV, 2021-12) ; ;
    Le, Linh-Vi
    ;
    ;
    BACKGROUND: With the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in early 2020, Mongolia implemented rapid emergency measures and did not report local transmission until November 2020. We conducted a national seroprevalence survey to monitor the burden of SARS-CoV-2 in Mongolia in the months surrounding the first local transmission. METHODS: During October-December 2020, participants were randomly selected using age stratification and invited for interviews and blood samples at local primary health centres. We screened for total SARS-CoV-2 antibodies, followed by two-step quantitative SARS-CoV-2 IgG serology tests for positive samples. Weighted and test-adjusted seroprevalences were estimated. We used chi-square, Fisher's exact and other tests to identify variables associated with seropositivity. FINDINGS: A total of 5000 subjects were enrolled. We detected SARS-CoV-2 IgG antibodies in 72 samples. Crude seroprevalence of SARS-CoV-2 antibodies was 1·44% (95%CI,1·21-1·67). Population weighted and test-adjusted seroprevalences were 1·36% (95%CI,1·11-1·63) and 1·45% (95%CI,1·11-1·63), respectively. Age, sex, geographical, and occupational factors were not associated with seropositivity (p>0·05). Symptoms and signs within past 3 months and seropositivity were not associated at the time of the survey (p>0·05). INTERPRETATION: SARS-CoV-2 seroprevalence in Mongolia was low in the first year of the pandemic potentially due to strong public health measures, including border restrictions, educational facilities closure, earlier adoption of mask-wearing and others. Our findings suggest large-scale community transmission could not have occurred up to November 2020 in Mongolia. Additional serosurveys are needed to monitor the local pandemic dynamic and estimate how far from herd immunity Mongolia will be following-up with vaccination programme in 2021 and 2022. FUNDING: World Health Organisation, WHO UNITY Studies initiative, with funding by the COVID-19 Solidarity Response Fund and the German Federal Ministry of Health (BMG) COVID-19 Research and development. TRANSLATION: Cyrillic and Traditional Mongolian translation of abstract is available on appendix section.
    Scopus© Citations 14
  • Some of the metrics are blocked by your 
    Item type:Publication,